Histogen Inc (HSTO)
0.3501
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Histogen Price to Book Value: 0.2751 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 0.275 |
April 22, 2024 | 0.275 |
April 19, 2024 | 0.118 |
April 18, 2024 | 0.3929 |
April 17, 2024 | 0.3929 |
April 16, 2024 | 0.3929 |
April 15, 2024 | 0.3929 |
April 12, 2024 | 0.3929 |
April 11, 2024 | 0.3929 |
April 10, 2024 | 0.3929 |
April 09, 2024 | 0.3929 |
April 08, 2024 | 0.3929 |
April 05, 2024 | 0.3929 |
April 04, 2024 | 0.3929 |
April 03, 2024 | 0.3929 |
April 02, 2024 | 0.3929 |
April 01, 2024 | 0.283 |
March 28, 2024 | 0.283 |
March 27, 2024 | 0.3143 |
March 26, 2024 | 0.3143 |
March 25, 2024 | 0.3065 |
March 22, 2024 | 0.2554 |
March 21, 2024 | 0.3143 |
March 20, 2024 | 0.2593 |
March 19, 2024 | 0.2593 |
Date | Value |
---|---|
March 18, 2024 | 0.2593 |
March 15, 2024 | 0.2593 |
March 14, 2024 | 0.2593 |
March 13, 2024 | 0.3065 |
March 12, 2024 | 0.3065 |
March 11, 2024 | 0.275 |
March 08, 2024 | 0.2593 |
March 07, 2024 | 0.3065 |
March 06, 2024 | 0.3065 |
March 05, 2024 | 0.2593 |
March 04, 2024 | 0.275 |
March 01, 2024 | 0.2475 |
February 29, 2024 | 0.2475 |
February 28, 2024 | 0.2475 |
February 27, 2024 | 0.2495 |
February 26, 2024 | 0.2495 |
February 23, 2024 | 0.2475 |
February 22, 2024 | 0.2515 |
February 21, 2024 | 0.3143 |
February 20, 2024 | 0.2475 |
February 16, 2024 | 0.2633 |
February 15, 2024 | 0.2672 |
February 14, 2024 | 0.2672 |
February 13, 2024 | 0.2672 |
February 12, 2024 | 0.2672 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.118
Minimum
Apr 19 2024
6.628
Maximum
Mar 19 2021
1.198
Average
0.4764
Median
May 04 2022
Price to Book Value Benchmarks
CEL-SCI Corp | 6.166 |
AIM ImmunoTech Inc | 2.238 |
IGC Pharma Inc | 3.034 |
NovaBay Pharmaceuticals Inc | 1.644 |
Protalix BioTherapeutics Inc | 2.644 |
Price to Book Value Related Metrics
PS Ratio | 78.77 |
Price | 0.3501 |
Earnings Yield | -802.6% |
Market Cap | 1.496M |